Deep brain stimulation procedures have been shown to reduce “tics,” or involuntary movements or outbursts, experienced by young adult individuals with Tourette’s syndrome, according to a new study. Results from the study were published last Friday in the Journal of Neurosurgery. Study researchers said the new data adds to a growing body which support DBS […]
Neuromodulation/Neurostimulation
AcelRx touts data from Dsuvia pain relief trials
AcelRx Pharmaceuticals (NSDQ:ACRX) touted efficacy and safety data today for its pain reliever, Dsuvia. The company’s lead drug candidate is composed of 30 sufentanil tablets delivered sublingually using a disposable, pre-filled single-dose applicator. Dsuvia is investigational and not approved in any country. The 4 late-phase studies enrolled 480 patients total. In 2 randomized studies, enrolled patients underwent bunionectomy […]
Gurnet Point buys Innocoll holdings for $209m
Healthcare investment fund Gurnet Point said today it will acquire Innocoll Holdings for approximately $209 million. Gurnet will put up $1.75 per share in cash and up to $4.90 in cash from a contingent value right, for a potential share value up to $6.65, the company said. During the offer period, Gurnet said it plans […]
Neural interface developer Synchron raises $10m in Series A
Minimally invasive neuromod developer Synchron said today it raised $10 million in a Series A round of financing to support its neural interface technology. The round was led by Neurotechnology Investors and joined by the U.S. Department of Defense, including the Defense Advanced Research Projects Agency. Campbell, Calif.-based Synchron said that the funds raised will […]
StimRelieve launches craniofacial chronic pain trial
Stimwave Technologies spinout StimRelieve said today it enrolled the 1st patient in a clincal trial of its implantable StimRelieve device designed to treat chronic craniofacial nerve pain. The Ft. Lauderdale, Fla.-based company’s device is designed to be implanted near inflicted painful nerves to modulate nerve activity and provide therapeutic relief, the company said. The device is powered […]
New Enterprise Associates gets in on SetPoint Medical
SetPoint Medical said today that it has received an investment from venture capital firm New Enterprise Associates. SetPoint is developing a neuromodulation device designed to stimulate the vagus nerve to trigger the body’s anti-inflammatory response, according to the company. Newly vested NEA joins existing investors Medtronic (NYSE:MDT), Boston Scientific (NYSE:BSX), GlaxoSmithKline‘s (NYSE:GSK) Action Potential Venture Capital […]
FDA panel rules that benefits of Endo’s Opana opioid no longer outweigh risks
An FDA advisory panel ruled yesterday that the benefits of Endo Pharmaceutical‘s opioid painkiller, Opana ER, no longer outweigh its risks. The painkiller has been linked to a 2015 HIV outbreak in Indiana after people addicted to opioids shared needles while injecting Opana. The panel voted 18 to 8 that the drug’s benefits do not […]
Pacira touts Phase IV study of Exparel anesthetic in total knee arthroplasty
Pacira Pharmaceuticals (NSDQ:PCRX) said today the Phase IV study of its Exparel bupivacaine liposome injection in patients undergoing total knee arthroplasty met its co-primary endpoints for postsurgical pain and opioid reduction. The anesthetic achieved statistical significance for secondary endpoints including time to 1st opioid use and the percentage of patients who did not require opioids […]
Minimally-invasive migraine treatment for adults works on kids, too
Migraine treatment that has been safe for adults has recently proven to be safe for use in children as well. The minimally-invasive treatment only takes a few minutes for children and teenagers to be able to feel the effects. The treatment involves a sphenopalatine ganglion (SPG) block that does not need needles. It uses a […]
Autonomic Technologies wins expanded CE Mark for migraine-treating microstim
Autonomic Technologies said today that it won an expanded indication to its CE Mark for the Pulsante SPG microstimulator system. The expanded indication includes pain relief for highly disabled migraine patients. The device, which was previously cleared for pain relief in patients with cluster headaches, is now also indicated for pain relief in migraine patients […]
Boston Scientific renews lease on Valencia neuromod facility, looks to add jobs
Boston Scientific (NYSE:BSX) this week signed a 10-year extension on the lease for its Valencia, Calif.-based facility, home to its neuromodulation group, according to a new report. The Marlborough, Mass.-based company will continue to operate its neuromod devision out of the 342,000 square foot facility in southern California, and may look to add jobs at the facility, according to […]